A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Immunic, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 600 shares of IMUX stock, worth $683. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 5,700 89.47%
Holding current value
$683
Previous $8,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.14 - $1.53 $2 - $3
2 New
2 $0
Q2 2023

Aug 14, 2023

SELL
$1.33 - $2.51 $8,114 - $15,313
-6,101 Reduced 76.45%
1,879 $4,000
Q1 2023

May 15, 2023

SELL
$1.35 - $2.87 $23,252 - $49,432
-17,224 Reduced 68.34%
7,980 $11,000
Q4 2022

Feb 14, 2023

BUY
$1.13 - $1.51 $28,480 - $38,058
25,204 New
25,204 $35,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $12.25 $1.45 Million - $5.66 Million
462,178 Added 1344.48%
496,554 $1.72 Million
Q1 2022

May 16, 2022

SELL
$9.54 - $14.26 $97,651 - $145,965
-10,236 Reduced 22.94%
34,376 $389,000
Q4 2021

Feb 14, 2022

BUY
$7.34 - $10.25 $225,360 - $314,705
30,703 Added 220.74%
44,612 $426,000
Q2 2021

Aug 16, 2021

SELL
$11.76 - $16.85 $108,415 - $155,340
-9,219 Reduced 39.86%
13,909 $170,000
Q4 2020

Feb 16, 2021

SELL
$14.8 - $20.37 $73,630 - $101,340
-4,975 Reduced 17.7%
23,128 $353,000
Q3 2020

Nov 16, 2020

BUY
$11.74 - $22.0 $329,929 - $618,266
28,103 New
28,103 $522,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $34.8M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.